The biotechnology business has witnessed important shifts in recent times, notably within the realm of each mergers and acquisitions (M&A) and collaborative agreements....
By STEVEN ZECOLA
Synthetic intelligence (“AI”) has taken root within the subject of drug discovery and growth and already has proven indicators of working...